Manuel Stingelin

Manuel Stingelin currently serves as Senior Director Finance for CMC and G&A at NewAmsterdam Pharma Corporation since November 2024. Prior experience includes roles at Vir Biotechnology, Inc., where responsibilities included Senior Director and Director positions in Corporate FP&A. At Bristol Myers Squibb, Manuel held multiple roles, culminating as Finance Associate Director for Cell Therapy Launch Readiness. Earlier positions include Head of Finance & Controlling at Natco AG, and financial roles at Klöckner Pentaplast and Huntsman. Academic credentials include an MBA from the University of Toronto's Rotman School of Management, a MAS in Corporate Finance from Lucerne University of Applied Sciences and Arts, and a BBA from the University of Applied Sciences and Arts Northwestern Switzerland FHNW.